We demonstrated that limiting methionine intake or targeting MAT2A efficiently suppresses the tumorigenicity of GBM tumorsphere cells, thus present a novel perspective on hypoxia-mediated maintenance of tumor-initiating cells. The gene discussed is MAT2A; the disease is glioblastoma.